Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Post-irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review.

Version 1 : Received: 12 December 2023 / Approved: 13 December 2023 / Online: 13 December 2023 (04:54:43 CET)

A peer-reviewed article of this Preprint also exists.

Parisi, S.; Gambardella, C.; Iovino, F.; Ruggiero, R.; Lucido, F.S.; Nesta, G.; Tolone, S.; Brusciano, L.; Fisone, F.; Mongardini, F.M.; Cozzolino, G.; Della Corte, C.M.; Napolitano, S.; Orditura, M.; Esposito, R.; Docimo, L. Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review. J. Clin. Med. 2024, 13, 567. Parisi, S.; Gambardella, C.; Iovino, F.; Ruggiero, R.; Lucido, F.S.; Nesta, G.; Tolone, S.; Brusciano, L.; Fisone, F.; Mongardini, F.M.; Cozzolino, G.; Della Corte, C.M.; Napolitano, S.; Orditura, M.; Esposito, R.; Docimo, L. Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review. J. Clin. Med. 2024, 13, 567.

Abstract

Breast Angiosarcoma is a rare malignancy, accounting less than 1% of all soft tissue. It comprises primitive and secondary subtypes, such as radiogenic breast angiosarcoma (RAS). Despite the multimodal treatment, angiosarcomas represent an incurable disease for many patients and represent a cause of substantial deterioration of their quality of life. Surgery represents the cornerstone in the management, but high recurrence rates are reported. Electrochemotherapy (ECT) is practicable locoregional treatment in patients with advanced angiosarcoma, in a multimodal therapeutic strategy. ECT palliative benefit includes optimal patient compliance, good local hemostasis control, and local responses. Considering that only 22 cases are described in literature, we reported a rare case of RAS treated with ECT, after a multidisciplinary approach including Next Generation Sequencing (NGS). A literature review about the feasibility of ECT in RAS management was also performed.

Keywords

breast angiosarcoma; post-irradiation angiosarcoma; elettrochemotherapy

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.